Marijuana Stocks

Much like the U.S. legal status on marijuana, the verdict on marijuana stocks is still up in the air. While the bulls like to think that the marijuana industry is about to explode with their optimism over the pending decriminalization and legalization of marijuana, the bears view marijuana stocks as a very risky investment to the point that they may be scams. Marijuana Penny Stocks such as Cannabis Science Inc (CBIS) are risky due to fact that they are in a grey legal area. But as Canada’s nascent legal marijuana market blossoms, many pot stocks are worth adding to your portfolio.

Related to Marijuana Stocks:

The Long THC-Short CBD Cannabis Trade Is Paying Off

By Wayne Duggan, InvestorPlace Contributor
Marijuana stocks have struggled in the past eight months. Going long THC stocks and short CBD stocks is a good way to bet on cannabis while mitigating risk.

9 Top Robinhood Stocks You May Want to Avoid Here

By Vince Martin, InvestorPlace Contributor
Many Robinhood stocks have soared as money flooded in at March lows. But the platform's investors have these nine names wrong.

9 Smaller Marijuana Stocks You Shouldn’t Ignore

By Josh Enomoto, InvestorPlace Contributor
Smaller and speculative marijuana stocks took a beating following the initial coronavirus strike. However, they could also generate massive profitability for the risk-tolerant speculator.

7 Troubled Marijuana Stocks That May Not Survive 2020

By David Moadel, InvestorPlace Contributor
There's no avoiding the fact that some or possibly even all of these marijuana stocks might not last through the end of the year.

10 Penny Stocks You’re Better Off Avoiding

By Vince Martin, InvestorPlace Contributor
Penny stocks by nature are risky. These 10 stocks have even higher-than-usual risks, which makes them dangerous for most investors.

10 Best ETFs for 2020: The Race Tightens With ‘New Normal’ Looming Ahead

By Robert Waldo, InvestorPlace Senior Web Editor
The landscape for best ETFs in 2020 has changed after the novel coronavirus pandemic with technology and cloud companies leading the bunch.

Buy Canopy Growth Stock Before Positive Momentum Returns

By InvestorPlace Research Staff
A major needle-mover around the corner could lead CGC stock to trend higher again. Get ahead of the crowd by buying today's pullback.

The Top 15 Stocks to Buy in 2020

By Luke Lango, InvestorPlace Senior Investment Analyst
The coronavirus pandemic has created once-in-a-lifetime buying opportunities in these strong stocks to buy for 2020.

4 Marijuana Stocks to Buy for the Big 2020 Rally

By Luke Lango, InvestorPlace Senior Investment Analyst
The marijuana stock rebound in 2020 has run into a brick wall, but the fundamentals supporting the industry continue to improve.

7 Marijuana Stocks for Loyal Cannabis Bulls

By Vince Martin, InvestorPlace Contributor
Marijuana stocks remain near the lows, and many remain challenged. But these seven names have the potential to rally through sector fears.

Hexo Stock Still Has a Major Cash Problem

By Wayne Duggan, InvestorPlace Contributor
Don't bother buying Hexo stock here. Instead, look for stronger cannabis stocks that have better balance sheets and bigger potential.

Buy Canopy Growth Stock as Cannabis Again Enters the Spotlight

By InvestorPlace Research Staff
Canopy Growth stock has been trading better lately, giving investors a glimpse of what CGC stock can do if it regains momentum.

Canopy Growth Has a Catalyst That Few Are Talking About

By InvestorPlace Research Staff
The devastation from the coronavirus spared very few sectors and marijuana wasn’t one of them. However, this has created a long-term catalyst for CGC stock that few are talking about.

Only a Miracle Can Save Tilray Stock Now

By Faizan Farooque, InvestorPlace Contributor
TLRY stock is down over 97% in under two years, and there's no stopping the free fall as the company struggles on multiple fronts.

Buy the Post-Earnings Dip in Canopy Growth Stock Now

By Luke Lango, InvestorPlace Senior Investment Analyst
Canopy Growth's fourth-quarter earnings report was not good. But the big-picture trends remain favorable, and CGC stock will bounce back.

Canopy Growth Stock Is Still Among the Most Compelling Marijuana Plays

By Alex Sirois, InvestorPlace Contributor
CGC stock is well-positioned to become a leader in the cannabis industry with its steady partnership with a beverage industry giant.

Tilray Stock Is a Loser in the Cannabis World

By InvestorPlace Research Staff
Compared to its innovative peers like Cronos and Canopy Growth, Tilray is destined to fail. That's why investors should avoid TLRY stock now.

Constellation Brands Must Exercise Warrants to Keep Canopy Growth Alive

By Mark R. Hake, CFA
Canadian Canopy Growth is burning through cash way too quickly. That's why CGC stock is relying on Constellation Brands for survival.

3 Numbers to Study Before Jumping on the Tilray Bandwagon

By Will Ashworth, InvestorPlace Contributor
Before you decide to buy or sell Tilray stock and move on to another cannabis play, at least take the time to consider three numbers from its quarterly report. I won’t say which way I’m leaning toward Tilray until the end -- the last time I wrote about TLRY in November, I cautioned investors to wait for a catalyst before buying -- but I can say that Tilray’s business isn’t nearly as bad as the headlines suggest. 
Load More